The Claim
In adults with obesity and prediabetes, 14 weeks of caloric restriction results in a 9.5% reduction in visceral fat, which is significantly greater than the 4.8% reduction observed with 1.8 mg/day liraglutide.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with obesity and prediabetes, 14 weeks of eating fewer calories reduces visceral fat by 9.5%, which is more than the 4.8% reduction seen with a daily dose of 1.8 mg of liraglutide.
See the scientific wording
In adults with obesity and prediabetes, 14 weeks of caloric restriction reduced visceral fat by 9.5%, significantly more than the 4.8% reduction seen with 1.8 mg/day liraglutide, suggesting caloric restriction is more effective at reducing this high-risk fat depot.
When a person eats fewer calories, the body breaks down stored fat in the belly area more aggressively and stops storing new fat there, leading to a bigger drop in belly fat than when a drug only reduces hunger.
What the research says
1 studyIn a study of adults with obesity and prediabetes, cutting calories for 14 weeks shrunk dangerous belly fat more than taking the drug liraglutide, proving that diet alone worked better than the medicine for this specific type of fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.